Next Article in Journal
Plasmon-Enhanced Piezo-Photocatalytic Degradation of Metronidazole Using Ag-Decorated ZnO Microtetrapods
Previous Article in Journal
Iohexol as an Emerging Contaminant Potentially Influencing Structural and Functional Changes in the Activated Sludge Microbiome
Previous Article in Special Issue
Graph Neural Networks vs. Traditional QSAR: A Comprehensive Comparison for Multi-Label Molecular Odor Prediction
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Volatile Organic Compounds Induced upon Viral Infection in Cell Culture: Uniform Background Study with Use of Viruses from Different Families

1
Department of Pathology, Division of Microbiology, The Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland
2
Department of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences, 50-357 Wrocław, Poland
3
Institute of Biological Bases of Animal Production, Faculty of Animal Sciences and Bioeconomy, University of Life Sciences in Lublin, 20-950 Lublin, Poland
4
Department of Reproduction and Clinic for Farm Animals, The Faculty of Veterinary Medicine, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland
5
VetAI.bio Ltd., London UB9 5NJ, UK
6
InstaDeep Ltd., London W2 1AS, UK
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(23), 4642; https://doi.org/10.3390/molecules30234642 (registering DOI)
Submission received: 22 October 2025 / Revised: 28 November 2025 / Accepted: 30 November 2025 / Published: 3 December 2025
(This article belongs to the Special Issue Analysis of Natural Volatile Organic Compounds (NVOCs))

Abstract

This study investigates the production of volatile organic compounds (VOCs) in RK-13 cells infected with three equine viruses representing different families: equine arteritis virus (EAV) (Arteriviridae), equine herpesvirus 1 (EHV-1) (Herpesviridae), and equine rhinitis B virus (ERBV) (Picornaviridae). VOCs, which are byproducts of cellular metabolism and potential non-invasive diagnostic markers, were analyzed using headspace solid-phase microextraction (HS-SPME) and gas chromatography–mass spectrometry (GC-MS). Since viruses do not possess intrinsic metabolic activity, the observed changes in the VOC profiles were attributed to host responses, such as metabolic reprogramming, oxidative stress, and apoptosis. We hypothesized that each viral infection induces distinct metabolic changes, resulting in characteristic VOC signatures that mirror the virus type, replication kinetics, and cytopathic effects. Notably, viruses with rapid cytopathic effects (e.g., EHV-1) were anticipated to trigger more pronounced VOC alterations. In our experimental design, RK-13 cells were infected at a multiplicity of infection of 1 and incubated for 24 h, 48 h, or 72 h. Distinct VOC profiles emerged, with significant elevations in compounds like 2-ethyl-1-hexanol, particularly in EHV-1 infections, and selective increases in acetophenone and benzaldehyde. Principal component analysis (PCA) of the VOC concentration data showed the clear separation of data from viruses from different families. These findings support the potential of VOC profiling as a rapid diagnostic tool for viral infections.

1. Introduction

Volatile organic compounds (VOCs) are chemicals that have a high vapor pressure at room temperature. Endogenous VOCs are products of metabolic activity in the body, and changes in these VOCs can be characteristic for age and specific disease [1]. Different biological samples, such as breath, urine, feces, body surface, and sweat, have been analyzed for their odor, serving as sources for detecting VOCs [2]. Various VOC types, including hydrocarbons (alkanes and alkenes), aldehydes, alcohols, ketones, aromatics, carboxylic acids, esters, ethers, and nitrogen- or sulfur-containing volatile compounds, have been identified in prior cancer research [3,4]. Also, the microbiome of an animal or human produces unique VOCs that can change under different circumstances, such as viral infection [5].
Viruses themselves do not possess any metabolic activity, and the composition of the viral particle (virion) is made up of lipids, DNA/RNA, and proteins, which are thought to be odorless; therefore, the production of VOCs is presumably associated with metabolic changes in infected cells associated with the viral replication cycle, oxidative stress, or induction of apoptosis [6]. In metabolomic studies, virus-infected cells are often characterized by increased aerobic glycolysis, elevated tricarboxylic acid cycle activity, enhanced oxidative phosphorylation, intensified glutaminolysis, and elevated fatty acid synthesis [7].
In the biomedical field, the analysis of volatile organic compounds (VOCs) produced by human fluids such as breath, urine, and feces, as well as tissues like skin and tumors, has been proposed as a non-invasive diagnostic tool for diseases [8,9,10].
Before the COVID-19 pandemic, there was very little work focused on the VOC analysis of viral infections [6,11,12,13]. In one study, VOC production by infected human B lymphocytes was analyzed for different subtypes of Influenza A. There were clear differences in the VOC profiles detected in noninfected and infected lymphocytes, as well as differences in compounds detected in samples derived from specific subtypes, times of infection, and multiplicities of infection (MOIs) [12]. In another study, the VOC analysis of cells infected with human respiratory viruses, including influenza and respiratory syncytial virus, was performed over time [13]. The study on the cell culture of rhinovirus and in volunteers infected with this virus showed that the decanes and other long-chain alkanes are increased in infected cells as well as in infected people, as measured in their breath [14]. Therefore, it is likely that the data generated from infected cell cultures can be translated into diagnostic tools for fast and rapid infectious disease diagnosis.
Although we have learned through many techniques which VOCs are produced during SARS-CoV-2 infection, both in studies performed on cell cultures as well as in affected people [15,16], little is known about the volatilomes of viruses of different families and, in particular, of animal viruses. As mentioned before, the volatilome of an infected human or animal is the resultant of many factors: the virus-induced metabolic changes in cells where it replicates, the VOCs produced upon immune stimulation, and the changes in the microbiome as an infection outcome [17]. However, preliminary in vitro studies on cell lines are fundamental for a proof of concept of the diagnostic, as well as for indication of potential VOC markers. As the microbiome of a particular individual is very variable, the immune response also differs across individuals, and the best markers come from infected cells themselves as a result of metabolome changes [18]. During acute infection (respiratory), most of the cells infected are epithelial cells. And these are the ones that produce characteristic VOC patterns. A recent meta-analysis on breath analysis in detection of COVID-19 through VOCs shows that many techniques used in detection of VOCs in patient breath showed high sensitivity and specificity (0.92 and 0.9, respectively) in detection of SARS-CoV-2 infection [19].
The development of new diagnostic techniques for acute viral infections would not have been possible without basic science and chemical analysis performed on virus-infected cell lines. Regardless of the extensive coronavirus research, there is still a need to look for differences in VOC profiles generated by infection of viruses from different families.
Volatile organic compounds (VOCs) generated during infections can be analyzed using various techniques, including gas chromatography–mass spectrometry (GC-MS) and gas chromatography–ion mobility spectrometry (GC-IMS). In this research, we utilized GC-MS in combination with solid-phase microextraction (SPME) for VOC analysis. Since its introduction by Arthur and Pawliszyn in 1990 [20], SPME has become a widely adopted method for VOC analysis, as it offers a straightforward and efficient approach by integrating sampling, isolation, and concentration into a single step [21,22]. During the process, heating the sample releases VOCs from the matrix, which then interact with the stationary phase. These compounds are subsequently separated in the GC column based on their chemical characteristics. Finally, the separated compounds are ionized and detected using a mass spectrometer [22].
Animal viruses are good models to study host–pathogen interactions, as most do not pose a threat to human personnel and results can be easily compared to human viruses. In this study we analyzed the VOC patterns of cells infected with equine arteritis virus (EAV), equine herpesvirus 1 (EHV-1), and equine rhinitis B virus (ERBV).
EAV is a virus in the Nidovirales order, Arteriviridae family, that is closely related to Coronaviridae. It is an enveloped RNA virus that replicates in cytoplasm, in replication centers of rearranged internal membranes. The virus causes a serious disease called equine viral arteritis that affects the respiratory and reproductive tracts. Upon viral infection, stallions may become persistent shedders of this virus [23].
Herpesviruses are a large family of enveloped viruses. They possess a large double-stranded DNA genome. The replication takes place in the nucleus, and the protein synthesis is divided into early gene expression and late gene expression. The EHV-1 is a causative agent of acute respiratory illness and abortion in pregnant mares, and the fatal myeloencephalopathy can also occur in horses [24].
Equine rhinitis B virus (ERBV) is a member of the family Picornaviridae and is a non-enveloped RNA virus that replicates in cytoplasm. After cellular rearrangements induced by the virus, the virions are released with the cell lysis and probably autophagy mechanisms [25,26]. ERBV causes acute respiratory disease in horses, and its incidence is rising worldwide [27].
The rabbit kidney 13 (RK-13) cell line is a continuous, epithelial cell line derived from the kidneys of a five-week-old rabbit. It is commonly used in the diagnosis of equine viruses, as recommended in manuals of the World Organisation for Animal Health, because they cause a visible cytopathic effect (CPE) in it, thereby enabling the isolation and identification of these pathogens [28,29].
The aim of this study is to analyze the volatilomes of three animal viruses that are able to replicate in one cell line in order to establish a uniform background. The hypothesis was that the metabolic changes induced upon viral infection vary in different virus species, resulting in the production of specific VOCs or changes in the concentration of VOCs already produced in the cells. A potential VOC marker for equine respiratory disease might be developed in the future.

2. Results

The CPE of RK-13 cells infected with EHV-1, EAV, or ERBV was visualized daily, before GC-MS sample collection. The CPE after virus infection was the most pronounced for EHV-1 at 24 h p.i., followed by ERBV (Figure 1A). The cytotoxicity assay showed that the cells were viable 24 h after infection, despite the visible CPE, but the viability decreased slightly after 48 h, while only half of the cells remained viable after 72 h, even in control cells (Figure 1B).
The CPE caused by EAV increased steadily over time, reaching a maximum at 72 h p.i. The titers of the viruses were the highest at 48 h p.i. for EHV-1 and ERBV, while for EAV, the highest titer was reached at 72 h p.i. (Figure 1C).
In the cell culture medium (background), we identified 22 compounds, while in cells, we identified 23 compounds, regardless of the infection state. Dimethyl trisulfide was the only absent VOC in the medium (Table 1). Other compounds were detected in the samples as well in the background medium, but in different amounts. Different classes of organic compounds, i.e., alcohols: 2-ethyl 1-hexanol, 1-octanol, and 1-dodecanol; ketones: acetophenone and 2-decanone; aldehydes: heptanal, octanal, nonanal, decanal, dodecanal, benzaldehyde, 2-decenal, and 2-undecenal; alkanes: dodecane, tridecane, and tetradecane; carboxylic acids: butanoic acids, pentanoic acid, hexanoic acid, heptanoic acid, octanoic acid, and nonanoic acid. As mentioned above, the dimethyl trisulfide (a sulfur-containing compound) was identified only in samples with cells (infected or uninfected cells), but not in the cell culture medium itself. The highest concentrations were observed for 2-ethyl-1-hexanol and acetophenone, especially for the infected cells (Figure 2).
At 24 h post-infection, the highest concentrations were observed for 2-ethyl-1-hexanol and acetophenone. However, the increase in 2-ethyl-1-hexanol was statistically significant only in EHV-1-infected cells (herpesvirus), while acetophenone was significantly elevated in EHV-1- and ERBV-infected cells. 1-octanol was significantly increased in EHV-1 and ERBV samples, while butanoic acid was significantly increased in herpesvirus-infected cells (Figure 3).
At 48 h post-infection, the only statistically significant changes were seen for 2-ethyl-1-hexanol, acetophenone, and dodecanal in ERBV-infected cells, but not in EAV or EHV-1 infections (Figure 3).
At 72 h post-infection, the significant elevation of 2-ethyl-1-hexanol was observed across all virus-infected cells. Acetophenone remained significantly increased—with the highest levels seen in the RNA viruses (EAV and ERBV) and a more modest rise in EHV-1. Benzaldehyde emerged as a new marker, significantly elevated in EAV but not significantly elevated in ERBV infections. This compound was not detected in EHV-1 samples or uninfected controls (Supplementary Table S1).
An analysis of variance revealed that at 24 h post-infection, the sample group (virus vs. control) had a significant effect on the VOC profiles (F(15, 22.49) = 2.81, p = 0.013, partial η2 = 0.652), with an observed noncentrality parameter of 42.11 and observed power of 0.934, indicating that the VOC compositions differed significantly between virus-infected and control samples even at this early stage. At 48 h post-infection, the effect of the virus type on VOCs approached significance (F(36, 3.68) = 3.64, p = 0.121, partial η2 = 0.973), with an observed noncentrality parameter of 131.21 and observed power of 0.437, reflecting a very large effect size. By 72 h post-infection, a significant overall effect of the virus type on the combined VOC profiles was observed (F(30, 3.61) = 7.95, p = 0.036, partial η2 = 0.985, observed power = 0.75), demonstrating that virus infection substantially altered the VOC composition compared with controls, with a very large effect size.
EHV-1 infection, which exhibited the fastest and most pronounced cytopathic effects as well as the highest titer at 24 h post-infection, showed the most abundant and significant changes in VOC production, including acetophenone, 2-ethyl-1-hexanol, butanoic acid, and 1-octanol. Similar significant increases in these compounds were noted in ERBV-infected cells, whereas in EAV-infected cells, only 2-ethyl-1-hexanol was significantly elevated at 24 h. This compound remained significantly altered in ERBV at the 48 h timepoint. Notably, acetophenone also increased significantly in the control sample at 48 h, suggesting a potential non-specific, distress-related response rather than a virus-specific effect. Furthermore, although dodecanal was detected in small amounts at 48 h, its increase was statistically significant in all virus-infected cells, especially in ERBV (an unenveloped virus). Finally, at 72 h, benzaldehyde was significantly elevated only in RNA virus infections (EAV and ERBV), while both acetophenone and 2-ethyl-1-hexanol reached their highest statistical significance in ERBV and EAV infections, with less pronounced changes in EHV-1.
Other compounds showed increased levels as well, especially in EHV-1 samples at the 24 h timepoint and in EAV at the 72 h timepoint; however, these changes were not statistically significant.
A multivariate analysis of the concentrations of the compounds (after removing background, i.e., concentrations of compounds in the medium) is presented in Figure 4. Uninfected samples are clustered on the left, whereas infected samples lay on the manifold below and to the left in the PC0-PC1 plot. We observe that the EHV-1 points (orange) tend to have high values along PC0, while the ERBV points are located to the left of the PC1 axis. The points of EAV, a virus that produced a less pronounced CPE, tend to be relatively low along the PC0 axis. The gradient structure of the data in the PC0-PC1 view indicates a strong statistical coupling between these principal component vectors.

3. Discussion

In RK-13 cells, the timing and severity of the CPEs and peak virus titers followed the known biology of each virus. EHV-1 produced the earliest and most conspicuous CPEs—syncytia, cell rounding, and detachment—by 24 h p.i., consistent with herpesviral membrane fusion activity and the extensive, stage-wise rewiring of the host cytoskeleton and gene expression that accompanies the early, intermediate, and late phases of the herpesviral lytic cycle. ERBV showed CPEs the second-fastest, in line with picornaviruses’ short replication cycles (often ≤6–8 h) and non-enveloped egress that proceeds primarily by cell lysis (and, in some systems, autophagy-linked pathways) [31,32]. By contrast, EAV displayed a gradual, “milder” CPE that accumulated through 72 h p.i., consistent with arteriviral replication on virus-induced double-membrane vesicles, the extensive remodeling of intracellular membranes, and particle release via the secretory pathway rather than abrupt cell lysis [33,34]. Cell viability measurements mirrored these trends: despite clear CPEs for EHV-1 and ERBV, their viability remained high at 24 h and declined modestly at 48 h, with a larger drop by 72 h. The 72 h decline seen even in controls likely reflects confluence and medium exhaustion rather than virus-specific toxicity. Virus production peaked at 48 h for EHV-1 and ERBV, whereas EAV reached its maximum at 72 h, indicating that a visible CPE does not strictly predict peak infectivity, and that EAV’s slower membrane-associated biogenesis shifts yield to later timepoints [34,35]. Overall, the kinetics of the CPE, viability, and titer in our system are in agreement with the established replication strategies of herpes-, picorna-, and arteriviruses in cell culture.
Our results indicate that 2-ethyl-1-hexanol is closely related to CPEs and viral titers, as it was elevated at various timepoints across all virus species, which matched these observations. This observation suggests that its increase may represent a general marker of cellular stress generated due to viral infection. Similar findings were reported in studies on human breast cancer and lung cancer cell cultures, where 2-ethyl-1-hexanol, indicative of cellular stress, and cyclohexanol were among the major compounds identified [4]. Moreover, 2-ethyl-1-hexanol has been detected in RSV-infected cells, but not in those infected with influenza [13]. In our study, the correlation of 2-ethyl-1-hexanol with both cytotoxicity and viral yield indicates that it may be produced as a byproduct of augmented metabolism—likely stemming from lipid metabolism or fatty acid oxidation—even though its precise biosynthetic pathway in mammalian cells remains unclear. Although this compound can also derive from the degradation of plasticizers such as di(2-ethylhexyl) phthalate (DEHP), our controls using medium incubated in plastic cell culture bottles (with background extraction) strongly support an endogenous origin, particularly in light of the oxidative stress induced by viral infection [36,37].
Acetophenone was another VOC detected in our experiments that is generated endogenously, potentially through the degradation of aromatic amino acids like phenylalanine or via other enzymatic reactions. It is considered a marker of altered metabolic states or cellular stress. For example, breath analyses have reported higher acetophenone levels in healthy individuals compared to those with chronic liver disease [38]. Additionally, studies on Zika-infected mice showed that infected animals emitted approximately tenfold higher levels of acetophenone than uninfected controls, and this compound was implicated in attracting mosquitoes [30]. In our in vitro model, where we ensured sterility (negative mycoplasma tests, use of antibiotics, and aseptic handling), the presence of acetophenone in both infected and control RK-13 cells suggests that it may indeed be a VOC product of the cells themselves.
Significant differences among groups were also observed for 1-octanol and butanoic acid in EHV-1-infected cells at 24 h post-infection. These compounds may arise from altered lipid metabolism, a known effect of DNA viruses—especially herpesviruses—which can induce changes in lipid biosynthesis and regulation [39]. At 48 h post-infection, a statistically significant increase in dodecanal levels was observed in ERBV-infected cells. This likely reflects the breakdown of membrane lipids due to cellular damage, consistent with ERBV’s reliance on cell lysis for viral release [40]. In contrast, EAV infection, which does not induce cell lysis but rather causes cell rounding and cytoskeletal rearrangements with virion budding via the secretory pathway [33], showed delayed VOC changes, with significant increases in 2-ethyl-1-hexanol and acetophenone observed only at later timepoints.
During the COVID-19 pandemic, breath analyses in SARS-CoV-2-infected patients commonly detected acetaldehyde, nonanal, octanal, and heptanal [19]. In our study, although nonanal, octanal, and heptanal were occasionally elevated, these differences were not statistically significant compared to controls. This may be attributed to the cell culture model used here, which lacks the in vivo immune response that can further modulate VOC release during infection.
We employed an MOI of 1 to ensure uniform infection and significant metabolic changes. Consistent with previous reports [11], our data indicate that ERBV and EHV-1 induce robust VOC changes by 24 h, whereas EAV-induced alterations become more apparent at 48 and 72 h. The differences in timing likely reflect variations in the replication cycles and pathogenic mechanisms of these viruses mentioned earlier. It is noteworthy that most VOCs were also detected in the culture medium, likely due to the presence of fetal bovine serum—a common supplement of animal origin that may itself contribute VOCs. However, the absence of dimethyl trisulfide in the medium, a product of sulfur-containing amino acid metabolism (e.g., cysteine and methionine) that we identified as a marker of cells, further supports the cellular origin of the detected VOCs.
Viral infections often induce a metabolic shift toward aerobic glycolysis (the Warburg effect) and favor fatty acid synthesis over fatty acid oxidation [41,42]. This shift can lead to enhanced lipid peroxidation and the formation of reactive aldehydes (such as hexanal, nonanal, and heptanal) and ketones (such as acetone and 2-butanone). The induction of VOCs like 2-ethyl-1-hexanol reflects these alterations in lipid handling and membrane turnover. Furthermore, 1-octanol, likely generated through lipid peroxidation, underscores the impact of oxidative stress on VOC production during viral infection.
Principal component analysis (PCA) of the volatilome reduces the dimensionality of complex VOC datasets and reveals the multivariate structure that single-compound tests may miss. It has been widely applied—from food quality and plant defense to environmental monitoring and non-invasive diagnostics from breath or urine—to discriminate samples by odor fingerprints rather than by individual markers [43]. In microbiology, PCA of VOC profiles can robustly separate bacterial species such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, even across different culture media, highlighting the stability of multivariate odor signatures [44]. Related work in bioprocessing shows that VOC emissions from cultured cells correlate with cell expansion in bioreactors (e.g., CHO and T-cell systems), and PCA on such signals has been used to monitor confluency and growth dynamics [45].
In this context, our cell culture data extend volatilome PCA to virology. Despite relatively few statistically significant univariate differences among individual VOCs, the PCA revealed clear, well-defined separation both by time post-infection and by virus, indicating that distinct viral species can be discriminated by their composite VOC signatures without relying on a single specific marker.
To the best of our knowledge, this is the first demonstration of the PCA-based discrimination of virus-derived volatilomes in a controlled cell culture model. Beyond classification, the temporal trajectories in PCA space suggest that volatilome readouts could inform operational decisions—such as pinpointing the optimal harvest time in vaccine production—by providing a non-invasive proxy for infection progression.
Collectively, these findings underscore the potential of VOC profiling in vitro as a diagnostic and process analytical tool and offer insight into the distinct metabolic perturbations elicited by different viral pathogens.

4. Summary

In summary, dimethyl trisulfide was identified as a marker of cellular metabolism since it was absent in the cell culture medium but consistently present in samples containing cells. In contrast, 2-ethyl-1-hexanol and acetophenone emerged as clear indicators of viral infection, with their concentrations correlating with viral replication, cytopathic effects, and changes over the course of infection. Butanoic acid was significantly elevated in infections caused by enveloped viruses (EHV-1 and EAV) but not in those caused by the unenveloped ERBV, suggesting increased fatty acid and membrane lipid metabolism in enveloped virus infections. Although no virus-specific VOCs were observed under our experimental conditions, the strength of this study lies in its simultaneous evaluation of viruses from distantly related families. Nonetheless, the subtle differences in metabolic responses across virus families and similar metabolic alterations pose challenges for VOC-based viral detection.

5. Study Limitations

Several limitations should be acknowledged. First, the RK-13 cell line, while offering a uniform and reproducible model, represents an immortalized system that may not fully capture the metabolic complexity of primary cells. This could influence both the range and concentration of VOCs detected. Moreover, RK-13 cells are routinely used in various diagnostic assays beyond equine virus studies, and their inherent metabolic characteristics may confound responses specific to equine viral infections. Finally, the sensitivity and specificity of the analytical technique (GC-MS) and potential variability in fiber absorption may have resulted in certain VOCs falling below the detection limit or being underestimated. These limitations underscore the need for future studies employing additional cell models, more sensitive analytical methods, and in vivo approaches to validate and extend these findings.

6. Materials and Methods

6.1. Cell Lines

The stable cell line rabbit kidney, RK-13 cells (ATCC CCL-37), was grown and maintained in EMEM (Capricorn Scientific, Ebsdorfergrund, Germany) supplemented with 10% fetal calf serum (FCS) sourced from Biological Industries (Cromwell, CT, USA), 100 U/mL of penicillin, 100 µg/mL of streptomycin, 1% L-glutamine, and 1% non-essential amino acid solution (Sartorius, Goettingen, Germany). The cells were maintained in a controlled environment at 37 °C with 5% CO2 and 95% humidity throughout the experiments.

6.2. Viruses

Equine arteritis virus (EAV), the Bucyrus reference strain, equine herpesvirus 1, the Valencia strain [36], and equine rhinitis B virus (ERBV), an Australian reference strain 1331/3/96, were propagated in RK-13 once and stored at −80 °C.

6.3. Titration

TCID 50 was performed on the RK-13 cell line for titration of the cell culture supernatants of infected and mock cells collected at the three indicated timepoints.

6.4. Cell Viability Assay

Cell viability was evaluated with a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay kit according to the manufacturer’s instructions (Abcam, Cambridge, UK) on a 96-well plate in triplicate 24, 48, and 72 h p.i. The absorbance was read in the Epoch microplate spectrophotometer (Agilent, BioTek, Warsaw, Poland) at 490 nm.

6.5. GC-MS Sample Preparation

The three T75 bottles of RK-13 cells were infected with MOI 1 of viruses: EAV, EHV-1, ERBV, or mock infection. Infected cells were maintained in EMEM supplemented with 0.5% FBS, 1% L-glutamine, 100 U/mL of penicillin, and 100 µg/mL of streptomycin. The control uninfected cells were prepared in the same manner as the infected ones (which included “infection” with medium, washing steps with PBS, and medium exchange). The background control was prepared in parallel by placing the medium in bottles (without the cells). The background sample was prepared in order to specify the exogenous VOCs from the medium, FBS, and plastic bottles. The bright-field pictures of cells were taken with an Axio Observer 1 inverted microscope (Zeiss, Oberkochen, Germany) equipped with a 10× objective.
Cells/control medium were incubated for 24 h, 48 h, or 72 h, an aliquot of 200 µL of cell culture supernatant was taken for titer estimation, and then the cells were scraped of the surface together with the medium and transferred to 10 mL chromatography glass vials (2 for each timepoint and virus for technical repetition) and stored at −80 °C until further processing. The experiment was performed in biological duplicate, in two technical replicates and two analytical replicates.

6.6. Headspace Solid-Phase Microextraction (HS-SPME)

Before analysis, 2-undecanone (99% purity) (Sigma-Aldrich, Steinheim, Germany) was added to the frozen matrix. For the extraction of volatile compounds, the following was used: SPME Arrow 1.10 mm 20 mm length, DVB/C-WR/PDMS (CTC Analytics AG, Zwingen, Switzerland). Before running each sample, the fiber was conditioned at 250 °C for 2 min and 3 min after desorption. Sample vials were incubated and extracted on a PAL autosampler in designated modules. Sample vials were incubated at 70 °C for 15 min, extracted at 70 °C for 30 min, and desorbed in split 1 mode at 250 °C for 3 min; the helium (analytical purity: 99.99997%, Air Products, Warsaw, Poland) flow rate was 1 mL/min.

6.7. Determination of VOCs

The analysis of VOCs on the SPME fiber was performed with a Shimadzu GCMS-QP2020 (Shimadzu Company, Kyoto, Japan) apparatus (single quadrupole). The separation was performed on a capillary column, Zebron ZB-5 (30 m × 0.25 mm × 0.25 µm) (Phenomenex, Torrance, CA, USA). The oven temperature was kept at 50 °C for 3 min, and it was heated up to 150 °C at a rate of 5 °C min−1, reaching a final temperature of 250 °C at 15 °C, and it was held at this temperature for 5 min. The total run time was 34.67 min. The MS parameters included electron ionization at 70 eV, an interface temperature of 250 °C, an ion source temperature of 250 °C, and Full Scan mode. Analysis was performed between 1 and 30 min with a range from 40 m/z to 400 m/z.
Identification of VOCs was carried out by comparing the experimentally obtained mass spectra and calculated linear retention indices (LRIs) with reference data. The LRIs were determined using a standard mixture of n-alkanes (C7–C30; Sigma-Aldrich, Steinheim, Germany) run under identical chromatographic conditions. Mass spectral data were interpreted using automated and manual matching against multiple spectral libraries, including the NIST WebBook, NIST23 databases. Where applicable, additional verification was performed through comparison with published literature data. Compounds were considered to be tentatively identified when both the mass spectrum match and LRI deviation fell within accepted confidence thresholds. This integrative approach enabled the reliable annotation of VOCs present in the headspaces of both virus-infected and uninfected cell cultures. Before analysis, samples were checked for the absence of 2-undecanone, which was used as an internal standard.
Compound concentrations were determined using the internal standard (IS) method. For each sample, peak areas of the analytes were extracted from the GC-MS chromatograms and normalized by the peak area of the internal standard to correct for ations in the injection volume and instrument response. The normalized ratios were then converted to absolute concentrations in µg per g of sample by multiplying by the known amount of internal standard added and dividing by the sample mass.

6.8. Statistical Analysis

Statistical analyses, in terms of analysis of variance (ANOVA) and multivariate analysis (heatmap matrices), were performed using Statistica version 13.1 (StatSoft, Tulsa, OK, USA). For each timepoint (24, 48, 72 h post-infection), a one-way ANOVA followed by Tukey’s HSD test was performed to compare VOC concentrations between virus-infected and control noninfected samples.
Data visualization in the form of a heatmap was performed in Python using the pandas, seaborn, and matplotlib libraries. Input data in TSV format were imported and processed with pandas, which enabled the correct handling of the decimal separator and the separation of the numerical part of the data matrix from the sample-identifying column. For visualization, the seaborn library was employed. To ensure clarity of presentation, automatic layout adjustment was applied, and the figure size was adapted to accommodate a larger number of variables.
GraphPad Prism version 10.4.1 was used to generate graphs (Figure 1B and Figure 3).
Statistical analysis of chromatography data for principal component analysis (PCA) was performed using tailor-made Python code, leveraging the pandas library for data handling, SciPy for statistical analysis, as well as the scikit-learn library for the training and evaluation of the machine learning models.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/molecules30234642/s1, Table S1: Concentrations of VOCs obtained in each readout.

Author Contributions

Conceptualization, A.K.M., A.S. (Antoni Szumny), M.D., A.K.-A. and M.W.; methodology, A.K.M., A.S. (Antoni Szumny) and M.J.S.; validation, J.Ł. and A.K.M.; formal analysis, A.K.M., A.K., M.O. and A.S. (Adam Szumowski); J.W., A.S. (Adam Szumowski) and M.J.S.; writing—A.K.M. and J.Ł.; writing—original draft preparation, A.S. (Antoni Szumny); writing—review and editing, A.S. (Antoni Szumny), J.W. and M.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded in whole by the National Center of Science, Poland, Sonata 16, grant number 2020/39/D/NZ6/03185, awarded to Anna Matczuk. The APC costs were co-financed by Wrocław University of Environmental and Life Sciences.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Raw data from GC-MS analysis were deposited in an open-access repository: DOI:10.57755/gcar-y540.

Acknowledgments

We thank Michael Veit and Minze Zhang from FU Berlin, Germany, for the RK-13 cells, and Jacob Trimpert from FU Berlin, Germany, for the EHV-1 Valencia strain. We also want to thank Magda Dunowska from the School of Veterinary Science, University of New Zealand, and Karol Stasiak from PIWET Puławy for the ERBV viral stock.

Conflicts of Interest

The authors declare no conflicts of interest. M.J.S. and M.W. are management board members and have securities from VetAI.bio Ltd. M.J.S. is an employee of InstaDeep Ltd. and has securities from BioNTech SE. The authors declare that these companies have no relevant financial or material interest that relates to the research presented in this paper.

Abbreviations

The following abbreviations are used in this manuscript:
VOCVolatile organic compound
CPECytopathic effect
EHV-1Equine herpesvirus 1
EAVEquine arteritis virus
ERBVEquine rhinitis B virus
TCID50Tissue culture infectious dose 50
MOIMultiplicity of infection
RK-13Rabbit kidney 13
GC-MSGas chromatography–mass spectrometry
GC-IMSGas chromatography–ion mobility spectrometry
PCAPrincipal component analysis

References

  1. Shirasu, M.; Touhara, K. The Scent of Disease: Volatile Organic Compounds of the Human Body Related to Disease and Disorder. J. Biochem. 2011, 150, 257–266. [Google Scholar] [CrossRef]
  2. Kafeenah, H.; Eze, M.O. Trends in volatile organic compound-based metabolomics for biomarker discovery. Microchem. J. 2025, 213, n113700. [Google Scholar] [CrossRef]
  3. Gouzerh, F.; Ganem, G.; Pichevin, A.; Dormont, L.; Thomas, F. Ability of Animals to Detect Cancer Odors. Biochim. Biophys. Acta (BBA)-Rev. Cancer 2023, 1878, 188850. [Google Scholar] [CrossRef] [PubMed]
  4. Filipiak, W.; Mochalski, P.; Filipiak, A.; Ager, C.; Cumeras, R.; Davis, C.E.; Agapiou, A.; Unterkofler, K.; Troppmair, J. A Compendium of Volatile Organic Compounds (VOCs) Released by Human Cell Lines. Curr. Med. Chem. 2016, 23, 2112–2131. [Google Scholar] [CrossRef]
  5. Thorn, R.M.S.; Greenman, J. Microbial Volatile Compounds in Health and Disease Conditions. J. Breath Res. 2012, 6, 24001. [Google Scholar] [CrossRef]
  6. Abd El Qader, A.; Lieberman, D.; Shemer Avni, Y.; Svobodin, N.; Lazarovitch, T.; Sagi, O.; Zeiri, Y. Volatile Organic Compounds Generated by Cultures of Bacteria and Viruses Associated with Respiratory Infections. Biomed. Chromatogr. 2015, 29, 1783–1790. [Google Scholar] [CrossRef]
  7. Sumbria, D.; Berber, E.; Mathayan, M.; Rouse, B.T. Virus Infections and Host Metabolism—Can We Manage the Interactions? Front. Immunol. 2021, 11, 594963. [Google Scholar] [CrossRef] [PubMed]
  8. Sethi, S.; Nanda, R.; Chakraborty, T. Clinical Application of Volatile Organic Compound Analysis for Detecting Infectious Diseases. Clin. Microbiol. Rev. 2013, 26, 462–475. [Google Scholar] [CrossRef]
  9. Amann, A.; de Lacy Costello, B.; Miekisch, W.; Schubert, J.; Buszewski, B.; Pleil, J.; Ratcliffe, N.; Risby, T. The Human Volatilome: Volatile Organic Compounds (VOCs) in Exhaled Breath, Skin Emanations, Urine, Feces and Saliva. J. Breath Res. 2014, 8, 34001. [Google Scholar] [CrossRef]
  10. Boots, A.W.; Bos, L.D.; van der Schee, M.P.; van Schooten, F.-J.; Sterk, P.J. Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises. Trends Mol. Med. 2015, 21, 633–644. [Google Scholar] [CrossRef]
  11. Schivo, M.; Aksenov, A.A.; Linderholm, A.L.; McCartney, M.M.; Simmons, J.; Harper, R.W.; Davis, C.E. Volatile Emanations from in Vitro Airway Cells Infected with Human Rhinovirus. J. Breath Res. 2014, 8, 37110. [Google Scholar] [CrossRef]
  12. Aksenov, A.A.; Sandrock, C.E.; Zhao, W.; Sankaran, S.; Schivo, M.; Harper, R.; Cardona, C.J.; Xing, Z.; Davis, C.E. Cellular Scent of Influenza Virus Infection. ChemBioChem 2014, 15, 1040–1048. [Google Scholar] [CrossRef]
  13. Purcaro, G.; Rees, C.A.; Wieland-Alter, W.F.; Schneider, M.J.; Wang, X.; Stefanuto, P.-H.; Wright, P.F.; Enelow, R.I.; Hill, J.E. Volatile Fingerprinting of Human Respiratory Viruses from Cell Culture. J. Breath Res. 2018, 12, 26015. [Google Scholar] [CrossRef]
  14. Kamal, F.; Kumar, S.; Edwards, M.R.; Veselkov, K.; Belluomo, I.; Kebadze, T.; Romano, A.; Trujillo-Torralbo, M.-B.; Shahridan Faiez, T.; Walton, R.; et al. Virus-Induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection. Am. J. Respir. Crit. Care Med. 2021, 204, 1075–1085. [Google Scholar] [CrossRef]
  15. Feuerherd, M.; Sippel, A.-K.; Erber, J.; Baumbach, J.I.; Schmid, R.M.; Protzer, U.; Voit, F.; Spinner, C.D. A Proof of Concept Study for the Differentiation of SARS-CoV-2, HCoV-NL63, and IAV-H1N1 in Vitro Cultures Using Ion Mobility Spectrometry. Sci. Rep. 2021, 11, 20143. [Google Scholar] [CrossRef]
  16. Mougang, Y.K.; Di Zazzo, L.; Minieri, M.; Capuano, R.; Catini, A.; Legramante, J.M.; Paolesse, R.; Bernardini, S.; Di Natale, C. Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19. iScience 2021, 24, 102851. [Google Scholar] [CrossRef]
  17. Lichtenstein, M.; Turjerman, S.; Pinto, J.M.; Barash, O.; Koren, O. Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds. mSystems 2021, 6, 10.1128/msystems.00104-21. [Google Scholar] [CrossRef]
  18. Manchester, M.; Anand, A. Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and Pathogenesis. Adv. Virus Res. 2017, 98, 57–81. [Google Scholar]
  19. Long, G.A.; Xu, Q.; Sunkara, J.; Woodbury, R.; Brown, K.; Huang, J.J.; Xie, Z.; Chen, X.; Fu, X.; Huang, J. A Comprehensive Meta-Analysis and Systematic Review of Breath Analysis in Detection of COVID-19 through Volatile Organic Compounds. Diagn. Microbiol. Infect. Dis. 2024, 109, 116309. [Google Scholar] [CrossRef] [PubMed]
  20. Arthur, C.L.; Pawliszyn, J. Solid Phase Microextraction with Thermal Desorption Using Fused Silica Optical Fibers. Anal. Chem. 1990, 62, 2145–2148. [Google Scholar] [CrossRef]
  21. Bojko, B.; Reyes-Garcés, N.; Bessonneau, V.; Goryński, K.; Mousavi, F.; Silva, E.A.S.; Pawliszyn, J. Solid-Phase Microextraction in Metabolomics. TrAC Trends Anal. Chem. 2014, 61, 168–180. [Google Scholar] [CrossRef]
  22. Beale, D.J.; Pinu, F.R.; Kouremenos, K.A.; Poojary, M.M.; Narayana, V.K.; Boughton, B.A.; Kanojia, K.; Dayalan, S.; Jones, O.A.H.; Dias, D.A. Review of Recent Developments in GC–MS Approaches to Metabolomics-Based Research. Metabolomics 2018, 14, 152. [Google Scholar] [CrossRef]
  23. MacLachlan, N.J.; Balasuriya, U.B. Equine Viral Arteritis. In The Nidoviruses; Perlman, S., Holmes, K.V., Eds.; Springer US: Boston, MA, USA, 2006; pp. 429–433. [Google Scholar]
  24. Khusro, A.; Aarti, C.; Rivas-Caceres, R.R.; Barbabosa -Pliego, A. Equine Herpesvirus-I Infection in Horses: Recent Updates on Its Pathogenicity, Vaccination, and Preventive Management Strategies. J. Equine Vet. Sci. 2020, 87, 102923. [Google Scholar] [CrossRef] [PubMed]
  25. Wutz, G.; Auer, H.; Nowotny, N.; Grosse, B.; Skern, T.; Kuechler, E. Equine Rhinovirus Serotypes 1 and 2: Relationship to Each Other and to Aphthoviruses and Cardioviruses. J. Gen. Virol. 1996, 77, 1719–1730. [Google Scholar] [CrossRef] [PubMed]
  26. Sun, D.; Wen, X.; Wang, M.; Mao, S.; Cheng, A.; Yang, X.; Jia, R.; Chen, S.; Yang, Q.; Wu, Y.; et al. Apoptosis and Autophagy in Picornavirus Infection. Front. Microbiol. 2019, 10, 2032. [Google Scholar] [CrossRef]
  27. Stasiak, K.; Dunowska, M.; Rola, J. Prevalence and Sequence Analysis of Equine Rhinitis Viruses among Horses in Poland. Viruses 2024, 16, 1204. [Google Scholar] [CrossRef]
  28. World Organisation for Animal Health (WOAH). Equine Viral Arteritis (Infection with Equine Arteritis Virus). In WOAH Terrestrial Manual 2024; World Organisation for Animal Health (WOAH): Paris, France, 2024. [Google Scholar]
  29. World Organisation for Animal Health (WOAH). Equine Rhinopneumonitis (Infection with Varicellovirus Equidalpha1). In WOAH Terrestrial Manual 2024; World Organisation for Animal Health (WOAH): Paris, France, 2024. [Google Scholar]
  30. Lin, J.-Y.; Chen, T.-C.; Weng, K.-F.; Chang, S.-C.; Chen, L.-L.; Shih, S.-R. Viral and Host Proteins Involved in Picornavirus Life Cycle. J. Biomed. Sci. 2009, 16, 103. [Google Scholar] [CrossRef]
  31. Kerr, S.-L.; Mathew, C.; Ghildyal, R. Rhinovirus and Cell Death. Viruses 2021, 13, 629. [Google Scholar] [CrossRef] [PubMed]
  32. Snijder, E.J.; Kikkert, M.; Fang, Y. Arterivirus Molecular Biology and Pathogenesis. J. Gen. Virol. 2013, 94, 2141–2163. [Google Scholar] [CrossRef]
  33. van der Hoeven, B.; Oudshoorn, D.; Koster, A.J.; Snijder, E.J.; Kikkert, M.; Bárcena, M. Biogenesis and Architecture of Arterivirus Replication Organelles. Virus Res. 2016, 220, 70–90. [Google Scholar] [CrossRef]
  34. Knoops, K.; Bárcena, M.; Limpens, R.W.A.L.; Koster, A.J.; Mommaas, A.M.; Snijder, E.J. Ultrastructural Characterization of Arterivirus Replication Structures: Reshaping the Endoplasmic Reticulum to Accommodate Viral RNA Synthesis. J. Virol. 2012, 86, 2474–2487. [Google Scholar] [CrossRef] [PubMed]
  35. Camini, F.C.; da Silva Caetano, C.C.; Almeida, L.T.; de Brito Magalhães, C.L. Implications of Oxidative Stress on Viral Pathogenesis. Arch. Virol. 2017, 162, 907–917. [Google Scholar] [CrossRef]
  36. Bażanów, B.; Michalczyk, K.; Kafel, A.; Chełmecka, E.; Skrzep-Poloczek, B.; Chwirot, A.; Nikiel, K.; Olejnik, A.; Suchocka, A.; Kukla, M.; et al. The Effects of Different Respiratory Viruses on the Oxidative Stress Marker Levels in an In Vitro Model: A Pilot Study. Int. J. Mol. Sci. 2024, 25, 12088. [Google Scholar] [CrossRef]
  37. Sinha, R.; Lockman, K.A.; Homer, N.Z.M.; Bower, E.; Brinkman, P.; Knobel, H.H.; Fallowfield, J.A.; Jaap, A.J.; Hayes, P.C.; Plevris, J.N. Volatomic Analysis Identifies Compounds That Can Stratify Non-Alcoholic Fatty Liver Disease. JHEP Rep. 2020, 2, 100137. [Google Scholar] [CrossRef]
  38. Zhang, H.; Zhu, Y.; Liu, Z.; Peng, Y.; Peng, W.; Tong, L.; Wang, J.; Liu, Q.; Wang, P.; Cheng, G. A Volatile from the Skin Microbiota of Flavivirus-Infected Hosts Promotes Mosquito Attractiveness. Cell 2022, 185, 2510–2522.e16. [Google Scholar] [CrossRef] [PubMed]
  39. Lange, P.T.; Lagunoff, M.; Tarakanova, V.L. Chewing the Fat: The Conserved Ability of DNA Viruses to Hijack Cellular Lipid Metabolism. Viruses 2019, 11, 119. [Google Scholar] [CrossRef]
  40. Kriegshäuser, G.; Hoey, E.M. Erbovirus BT—The Springer Index of Viruses; Tidona, C., Darai, G., Eds.; Springer: New York, NY, USA, 2011; pp. 1301–1305. ISBN 978-0-387-95919-1. [Google Scholar]
  41. Ritter, J.B.; Wahl, A.S.; Freund, S.; Genzel, Y.; Reichl, U. Metabolic Effects of Influenza Virus Infection in Cultured Animal Cells: Intra- and Extracellular Metabolite Profiling. BMC Syst. Biol. 2010, 4, 61. [Google Scholar] [CrossRef]
  42. Heaton, N.S.; Perera, R.; Berger, K.L.; Khadka, S.; LaCount, D.J.; Kuhn, R.J.; Randall, G. Dengue Virus Nonstructural Protein 3 Redistributes Fatty Acid Synthase to Sites of Viral Replication and Increases Cellular Fatty Acid Synthesis. Proc. Natl. Acad. Sci. USA 2010, 107, 17345–17350. [Google Scholar] [CrossRef] [PubMed]
  43. Greenacre, M.; Groenen, P.J.F.; Hastie, T.; D’Enza, A.I.; Markos, A.; Tuzhilina, E. Principal Component Analysis. Nat. Rev. Methods Primers 2022, 2, 100. [Google Scholar] [CrossRef]
  44. Fitzgerald, S.; Holland, L.; Morrin, A. An Investigation of Stability and Species and Strain-Level Specificity in Bacterial Volatilomes. Front. Microbiol. 2021, 12, 693075. [Google Scholar] [CrossRef]
  45. McCartney, M.M.; Yamaguchi, M.S.; Bowles, P.A.; Gratch, Y.S.; Iyer, R.K.; Linderholm, A.L.; Ebeler, S.E.; Kenyon, N.J.; Schivo, M.; Harper, R.W.; et al. Volatile Organic Compound (VOC) Emissions of CHO and T Cells Correlate to Their Expansion in Bioreactors. J. Breath Res. 2020, 14, 16002. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) Bright-field images of RK-13 cell monolayers: uninfected control and cultures infected with EHV-1 (equine herpesvirus 1), EAV (equine arteritis virus), or ERBV (equine rhinitis B virus). (B) Cell viability measured by MTS assay (OD, optical density). (C) Virus titers determined by TCID50 assay and cytopathic effect (CPE) scoring (“+” mild; “++” moderate; “+++” extensive). p.i., post-infection.
Figure 1. (A) Bright-field images of RK-13 cell monolayers: uninfected control and cultures infected with EHV-1 (equine herpesvirus 1), EAV (equine arteritis virus), or ERBV (equine rhinitis B virus). (B) Cell viability measured by MTS assay (OD, optical density). (C) Virus titers determined by TCID50 assay and cytopathic effect (CPE) scoring (“+” mild; “++” moderate; “+++” extensive). p.i., post-infection.
Molecules 30 04642 g001
Figure 2. Heatmaps of mean concentrations of volatile organic compounds (VOCs) in infected cultures at different timepoints after infection (p.i., post-infection): 24 h p.i. (left panel); 48 h p.i. (middle panel); 72 h p.i. (right panel). Control—uninfected cells; EHV-1—equine herpesvirus 1; EAV:—equine arteritis virus; ERBV—equine rhinitis B virus. Scales in μg per g.
Figure 2. Heatmaps of mean concentrations of volatile organic compounds (VOCs) in infected cultures at different timepoints after infection (p.i., post-infection): 24 h p.i. (left panel); 48 h p.i. (middle panel); 72 h p.i. (right panel). Control—uninfected cells; EHV-1—equine herpesvirus 1; EAV:—equine arteritis virus; ERBV—equine rhinitis B virus. Scales in μg per g.
Molecules 30 04642 g002
Figure 3. Mean concentrations of individual VOCs (μg per g) across experimental timepoints. A star (*) denotes a statistically important increase in the concentration of a particular VOC in virus-infected samples in comparison to the concentration in uninfected control samples at an indicated timepoint; p < 0.05 (one-way ANOVA). p.i.—post-infection; EHV-1—equine herpesvirus 1; ERBV—equine rhinitis virus B; EAV—equine arteritis virus. Graphs were generated with GraphPad Prims.
Figure 3. Mean concentrations of individual VOCs (μg per g) across experimental timepoints. A star (*) denotes a statistically important increase in the concentration of a particular VOC in virus-infected samples in comparison to the concentration in uninfected control samples at an indicated timepoint; p < 0.05 (one-way ANOVA). p.i.—post-infection; EHV-1—equine herpesvirus 1; ERBV—equine rhinitis virus B; EAV—equine arteritis virus. Graphs were generated with GraphPad Prims.
Molecules 30 04642 g003
Figure 4. Multivariate analysis of VOC profiles in virus-infected and uninfected cell culture samples. Principal component analysis (PCA) of VOC concentration data, showing separation of EAV-infected (blue), ERBV-infected (green), EHV-1-infected (orange), and control uninfected (red) samples along the first principal component and separation time-wise along the second principal component. Data shown for both biological replicates. The legend for both plots is shared.
Figure 4. Multivariate analysis of VOC profiles in virus-infected and uninfected cell culture samples. Principal component analysis (PCA) of VOC concentration data, showing separation of EAV-infected (blue), ERBV-infected (green), EHV-1-infected (orange), and control uninfected (red) samples along the first principal component and separation time-wise along the second principal component. Data shown for both biological replicates. The legend for both plots is shared.
Molecules 30 04642 g004
Table 1. The table summarizes all VOCs identified in this study, including their experimental linear retention indices (LRIs), corresponding literature LRIs, retention index deviations (ΔLRIs), mass spectral match factors, characteristic fragment ions (m/z), and relevant comments on biological relevance or infection-associated changes. Experimental LRIs were calculated using an n-alkane series and compared with published reference values. VOCs showing statistically significant elevation at specific timepoints post-infection (p.i.) are indicated accordingly. Literature comments include previously reported associations with viral infections (e.g., SARS-CoV-2, RSV, Zika virus) or other biological systems where applicable (in green font). The internal standard (2-undecanone) is included for reference.
Table 1. The table summarizes all VOCs identified in this study, including their experimental linear retention indices (LRIs), corresponding literature LRIs, retention index deviations (ΔLRIs), mass spectral match factors, characteristic fragment ions (m/z), and relevant comments on biological relevance or infection-associated changes. Experimental LRIs were calculated using an n-alkane series and compared with published reference values. VOCs showing statistically significant elevation at specific timepoints post-infection (p.i.) are indicated accordingly. Literature comments include previously reported associations with viral infections (e.g., SARS-CoV-2, RSV, Zika virus) or other biological systems where applicable (in green font). The internal standard (2-undecanone) is included for reference.
No.VOC NameExperimental LRILiterature LRIΔLRIMS Match (%)Key Ions (m/z)CASMolecular FormulaComments
1.Butanoic acid 805803−29060, 73, 88107-92-6C4H8O2Significantly elevated 24 h p.i. with EHV-1.
2.Pentanoic acid 89790149160, 73, 87109-52-4C5H10O2
3.Heptanal902901−18155, 70111-71-7C7H14OElevated in SARS-CoV-2 studies. [19]
4.Benzaldehyde 967962−59577, 105, 106100-52-7C7H6OSignificantly elevated 72 h p.i. with EAV.
5.Dimethyl trisulfide 975971−48560, 1263658-80-8C2H6S3Absent in medium.
6.Hexanoic acid 98799039560, 101, 115142-62-1C6H12O2
7.Octanal 10041003−18670, 110124-13-0C8H16OElevated in SARS-CoV-2 studies [19]
8.2-ethyl-1-hexanol 10321030−29570, 157104-76-7C8H18OElevated in infected cells in this study.
Reported in cancer research studies. [4]
RSV-infected cells. [13]
9.Acetophenone 10711066−59777, 10598-86-2C8H8OElevated in infected cells in this study.
Elevated in Zika virus-infected mice [30]
10.1-Octanol 10751070−59255, 70, 130111-87-5C8H18OSignificantly elevated 24 h p.i. with EHV-1 and ERBV.
11.Heptanoic acid 10791078−18987, 101, 129111-14-8C7H14O2
12.Nonanal 11061104−29657, 70, 98124-19-6C9H18OElevated in SARS-CoV-2 studies. [19]
13.Octanoic acid 11761180482101, 115, 143124-07-2C8H16O2
14.2-Decanone 11941193−18771, 170693-54-9C10H20O
15.Dodecane 1199120019657, 71, 170112-40-3C12H26
16.Decanal 1206120609670, 95, 155112-31-2C10H20O
17.2-Decenal1263126309269, 83, 1533913-71-1C10H18O
18.Nonanoic acid 1268127359487, 101, 129112-05-0C9H18O2
19.2-Undecanone 1294129409643, 58, 71112-12-9C11H22OInternal standard
20.Tridecane 1298130029657, 71, 85629-50-5C13H28
21.2-Undecenal 1364136738683, 1242463-77-6C11H20O
22.Tetradecane 1397140039783, 113629-59-4C14H30
23.Dodecanal1408140919357, 70, 156112-54-9C12H24OSignificantly elevated 24 h p.i. in EHV-1 and 48 h p.i. with ERBV.
24.1-Dodecanol 14761474−29255, 70, 168112-53-8C12H26O
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Matczuk, A.K.; Wolska, J.; Olszowy, M.; Kublicka, A.; Szumowski, A.; Kokocińska-Alexandre, A.; Dzięcioł, M.; Łyczko, J.; Woszczyło, M.; Skwark, M.J.; et al. Volatile Organic Compounds Induced upon Viral Infection in Cell Culture: Uniform Background Study with Use of Viruses from Different Families. Molecules 2025, 30, 4642. https://doi.org/10.3390/molecules30234642

AMA Style

Matczuk AK, Wolska J, Olszowy M, Kublicka A, Szumowski A, Kokocińska-Alexandre A, Dzięcioł M, Łyczko J, Woszczyło M, Skwark MJ, et al. Volatile Organic Compounds Induced upon Viral Infection in Cell Culture: Uniform Background Study with Use of Viruses from Different Families. Molecules. 2025; 30(23):4642. https://doi.org/10.3390/molecules30234642

Chicago/Turabian Style

Matczuk, Anna Karolina, Julia Wolska, Maria Olszowy, Agata Kublicka, Adam Szumowski, Agata Kokocińska-Alexandre, Michał Dzięcioł, Jacek Łyczko, Martyna Woszczyło, Marcin J. Skwark, and et al. 2025. "Volatile Organic Compounds Induced upon Viral Infection in Cell Culture: Uniform Background Study with Use of Viruses from Different Families" Molecules 30, no. 23: 4642. https://doi.org/10.3390/molecules30234642

APA Style

Matczuk, A. K., Wolska, J., Olszowy, M., Kublicka, A., Szumowski, A., Kokocińska-Alexandre, A., Dzięcioł, M., Łyczko, J., Woszczyło, M., Skwark, M. J., & Szumny, A. (2025). Volatile Organic Compounds Induced upon Viral Infection in Cell Culture: Uniform Background Study with Use of Viruses from Different Families. Molecules, 30(23), 4642. https://doi.org/10.3390/molecules30234642

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop